{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:59:32Z","timestamp":1764046772984,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Liver Disease Prevention and Treatment Research Foundation, Taiwan, National Taiwan University Hospital","award":["107-S3859"],"award-info":[{"award-number":["107-S3859"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00198-019-05116-1","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T18:03:37Z","timestamp":1565028217000},"page":"2289-2297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves\u2019 diseases: a case-control study"],"prefix":"10.1007","volume":"30","author":[{"given":"C.-H.","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-K.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7424-1358","authenticated-orcid":false,"given":"C.-W.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-S.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-R.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"5116_CR1","doi-asserted-by":"publisher","unstructured":"Smith TJ, Hegedus L (2016) Graves\u2019 disease. N Engl J Med 375 (16):1552\u20131565. doi:\nhttps:\/\/doi.org\/10.1056\/NEJMra1510030","DOI":"10.1056\/NEJMra1510030"},{"issue":"3","key":"5116_CR2","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/eje-15-0118","volume":"173","author":"F Mirza","year":"2015","unstructured":"Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173(3):R131\u2013R151. \nhttps:\/\/doi.org\/10.1530\/eje-15-0118","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"5116_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066711","volume":"8","author":"F Brandt","year":"2013","unstructured":"Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedus L, Brix TH (2013) Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS One 8(6):e66711. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0066711","journal-title":"PLoS One"},{"issue":"12","key":"5116_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144599","volume":"10","author":"SW Cho","year":"2015","unstructured":"Cho SW, Bae JH, Noh GW, Kim YA, Moon MK, Park KU, Song J, Yi KH, Park do J, Chung JK, Cho BY, Park YJ (2015) The presence of thyroid-stimulation blocking antibody prevents high bone turnover in untreated premenopausal patients with Graves\u2019 disease. PLoS One 10(12):e0144599. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0144599","journal-title":"PLoS One"},{"issue":"1","key":"5116_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1067\/mpd.2000.106219","volume":"137","author":"N Lucidarme","year":"2000","unstructured":"Lucidarme N, Ruiz JC, Czernichow P, Leger J (2000) Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves\u2019 disease. J Pediatr 137(1):56\u201362. \nhttps:\/\/doi.org\/10.1067\/mpd.2000.106219","journal-title":"J Pediatr"},{"issue":"6","key":"5116_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1365-2265.2007.02824.x","volume":"66","author":"SE Park","year":"2007","unstructured":"Park SE, Cho MA, Kim SH, Rhee Y, Kang ES, Ahn CW, Cha BS, Lee EJ, Kim KR, Lee HC, Lim SK (2007) The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves\u2019 disease. Clin Endocrinol 66(6):854\u2013858. \nhttps:\/\/doi.org\/10.1111\/j.1365-2265.2007.02824.x","journal-title":"Clin Endocrinol"},{"issue":"6","key":"5116_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/105072503322238854","volume":"13","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. Thyroid 13(6):585\u2013593. \nhttps:\/\/doi.org\/10.1089\/105072503322238854","journal-title":"Thyroid"},{"issue":"7","key":"5116_CR8","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1210\/jc.2004-2498","volume":"90","author":"H Yamashita","year":"2005","unstructured":"Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, Kazama JJ, Fukagawa M, Noguchi S (2005) Fibroblast growth factor-23 in patients with Graves\u2019 disease before and after antithyroid therapy: its important role in serum phosphate regulation. J Clin Endocrinol Metab 90(7):4211\u20134215. \nhttps:\/\/doi.org\/10.1210\/jc.2004-2498","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5116_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1210\/jcem.85.3.6457","volume":"85","author":"H Pantazi","year":"2000","unstructured":"Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85(3):1099\u20131106. \nhttps:\/\/doi.org\/10.1210\/jcem.85.3.6457","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"5116_CR10","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1001\/jama.2015.16535","volume":"314","author":"HB Burch","year":"2015","unstructured":"Burch HB, Cooper DS (2015) Management of Graves disease: a review. JAMA 314(23):2544\u20132554. \nhttps:\/\/doi.org\/10.1001\/jama.2015.16535","journal-title":"JAMA"},{"issue":"6","key":"5116_CR11","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.2337\/dc12-1452","volume":"36","author":"WY Ma","year":"2013","unstructured":"Ma WY, Yang CY, Shih SR, Hsieh HJ, Hung CS, Chiu FC, Lin MS, Liu PH, Hua CH, Hsein YC, Chuang LM, Lin JW, Wei JN, Li HY (2013) Measurement of waist circumference: midabdominal or iliac crest? Diabetes Care 36(6):1660\u20131666. \nhttps:\/\/doi.org\/10.2337\/dc12-1452","journal-title":"Diabetes Care"},{"issue":"11","key":"5116_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112355","volume":"9","author":"CS Hung","year":"2014","unstructured":"Hung CS, Lee JK, Yang CY, Hsieh HR, Ma WY, Lin MS, Liu PH, Shih SR, Liou JM, Chuang LM, Chen MF, Lin JW, Wei JN, Li HY (2014) Measurement of visceral fat: should we include retroperitoneal fat? PLoS One 9(11):e112355. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0112355","journal-title":"PLoS One"},{"key":"5116_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep39777","volume":"7","author":"TY Yu","year":"2017","unstructured":"Yu TY, Wei JN, Kuo CH, Liou JM, Lin MS, Shih SR, Hua CH, Hsein YC, Hsu YW, Chuang LM, Lee MK, Hsiao CH, Wu MS, Li HY (2017) The impact of gastric atrophy on the incidence of diabetes. Sci Rep 7:39777. \nhttps:\/\/doi.org\/10.1038\/srep39777","journal-title":"Sci Rep"},{"issue":"3","key":"5116_CR14","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/erc-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18(3):R53\u2013R77. \nhttps:\/\/doi.org\/10.1530\/erc-11-0006","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"5116_CR15","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1210\/jcem.84.10.6071","volume":"84","author":"J Sanders","year":"1999","unstructured":"Sanders J, Oda Y, Roberts S, Kiddie A, Richards T, Bolton J, McGrath V, Walters S, Jaskolski D, Furmaniak J, Smith BR (1999) The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. J Clin Endocrinol Metab 84(10):3797\u20133802. \nhttps:\/\/doi.org\/10.1210\/jcem.84.10.6071","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5116_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1590\/1806-9282.62.04.368","volume":"62","author":"HW Cabral","year":"2016","unstructured":"Cabral HW, Andolphi BF, Ferreira BV, Alves DC, Morelato RL, Chambo AF, Borges LS (2016) The use of biomarkers in clinical osteoporosis. Rev Assoc Med Bras 62(4):368\u2013376. \nhttps:\/\/doi.org\/10.1590\/1806-9282.62.04.368","journal-title":"Rev Assoc Med Bras"},{"issue":"5","key":"5116_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1590\/0004-2730000003311","volume":"58","author":"LF Cardoso","year":"2014","unstructured":"Cardoso LF, Maciel LM, Paula FJ (2014) The multiple effects of thyroid disorders on bone and mineral metabolism. Arq Bras Endocrinol Metabol 58(5):452\u2013463","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"5116_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1210\/endo.140.4.6658","volume":"140","author":"AI Alcalde","year":"1999","unstructured":"Alcalde AI, Sarasa M, Raldua D, Aramayona J, Morales R, Biber J, Murer H, Levi M, Sorribas V (1999) Role of thyroid hormone in regulation of renal phosphate transport in young and aged rats. Endocrinology 140(4):1544\u20131551. \nhttps:\/\/doi.org\/10.1210\/endo.140.4.6658","journal-title":"Endocrinology"},{"issue":"1","key":"5116_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1042\/bj20090671","volume":"427","author":"M Ishiguro","year":"2010","unstructured":"Ishiguro M, Yamamoto H, Masuda M, Kozai M, Takei Y, Tanaka S, Sato T, Segawa H, Taketani Y, Arai H, Miyamoto K, Takeda E (2010) Thyroid hormones regulate phosphate homoeostasis through transcriptional control of the renal type IIa sodium-dependent phosphate co-transporter (Npt2a) gene. Biochem J 427(1):161\u2013169. \nhttps:\/\/doi.org\/10.1042\/bj20090671","journal-title":"Biochem J"},{"issue":"3","key":"5116_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11914-019-00507-z","volume":"17","author":"M Zhou","year":"2019","unstructured":"Zhou M, Li S, Pathak JL (2019) Pro-inflammatory cytokines and osteocytes. Current osteoporosis reports 17(3):97\u2013104. \nhttps:\/\/doi.org\/10.1007\/s11914-019-00507-z","journal-title":"Current osteoporosis reports"},{"issue":"6","key":"5116_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00223-016-0116-8","volume":"98","author":"JL Pathak","year":"2016","unstructured":"Pathak JL, Bakker AD, Luyten FP, Verschueren P, Lems WF, Klein-Nulend J, Bravenboer N (2016) Systemic inflammation affects human osteocyte-specific protein and cytokine expression. Calcif Tissue Int 98(6):596\u2013608. \nhttps:\/\/doi.org\/10.1007\/s00223-016-0116-8","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"5116_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000311519","volume":"18","author":"AB Pedro","year":"2011","unstructured":"Pedro AB, Romaldini JH, Takei K (2011) Changes of serum cytokines in hyperthyroid Graves\u2019 disease patients at diagnosis and during methimazole treatment. Neuroimmunomodulation 18(1):45\u201351. \nhttps:\/\/doi.org\/10.1159\/000311519","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"5116_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266\u2013281. \nhttps:\/\/doi.org\/10.1056\/NEJMra070553","journal-title":"N Engl J Med"},{"issue":"3","key":"5116_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.44","volume":"13","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 13(3):17044. \nhttps:\/\/doi.org\/10.1038\/nrdp.2017.44","journal-title":"Nat Rev Dis Primers"},{"key":"5116_CR25","first-page":"1254","volume-title":"Williams textbook of endocrinology. 13 edn","author":"F Bringhurst","year":"2016","unstructured":"Bringhurst F, Demay M, Kronenberg H (2016) Hormones and disorders of mineral metabolism. In: Melmed S, Polonsky K, Larsen P, Kronenberg H (eds) Williams textbook of endocrinology. 13 edn. Elsevier, Philadelphia, pp 1254\u20131322"},{"issue":"12","key":"5116_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003975","volume":"9","author":"H Olauson","year":"2013","unstructured":"Olauson H, Lindberg K, Amin R, Sato T, Jia T, Goetz R, Mohammadi M, Andersson G, Lanske B, Larsson TE (2013) Parathyroid-specific deletion of klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion. PLoS Genet 9(12):e1003975. \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1003975","journal-title":"PLoS Genet"},{"key":"5116_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/978-1-4614-0887-1_6","volume":"728","author":"J Silver","year":"2012","unstructured":"Silver J, Naveh-Many T (2012) FGF23 and the parathyroid. Adv Exp Med Biol 728:92\u201399. \nhttps:\/\/doi.org\/10.1007\/978-1-4614-0887-1_6","journal-title":"Adv Exp Med Biol"},{"issue":"8015","key":"5116_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(77)92995-6","volume":"1","author":"L Mosekilde","year":"1977","unstructured":"Mosekilde L, Lund B, Sorensen OH, Christensen MS, Melsen F (1977) Serum-25-hydroxycholecalciferol in hyperthyroidism. Lancet 1(8015):806\u2013807","journal-title":"Lancet"},{"key":"5116_CR29","first-page":"334","volume-title":"Williams texbook of endocrinology","author":"D Salvatore","year":"2016","unstructured":"Salvatore D, Davies T, Schlumberger M, Hay I, Larsen P (2016) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky K, Larsen P, Kronenberg H (eds) Williams texbook of endocrinology, 13th edn. Elsevier, Philadelphia, pp 334\u2013368","edition":"13"},{"issue":"2","key":"5116_CR30","first-page":"117","volume":"29","author":"HP Bhattoa","year":"2018","unstructured":"Bhattoa HP (2018) Laboratory aspects and clinical utility of bone turnover markers. Ejifcc 29(2):117\u2013128","journal-title":"Ejifcc"},{"issue":"1","key":"5116_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1756-6614-6-11","volume":"6","author":"MA Ercolano","year":"2013","unstructured":"Ercolano MA, Drnovsek ML, Silva Croome MC, Moos M, Fuentes AM, Viale F, Feldt-Rasmussen U, Gauna AT (2013) Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves\u2019 disease. Thyroid Res 6(1):11. \nhttps:\/\/doi.org\/10.1186\/1756-6614-6-11","journal-title":"Thyroid Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05116-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:22:48Z","timestamp":1596496968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05116-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["5116"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05116-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consents were signed by all participants prior to the study, and ethical approval was obtained from the Ethics Committee of NTUH (protocol number 201105045RC, 201107013RC, and 201411013RINB).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}